Cargando…

Flower Pollen Extract in Association with Vitamins (Deprox 500(®)) Versus Serenoa repens in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Comparative Analysis of Two Different Treatments

OBJECTIVE: Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) is re-ported in the literature ranging from 1 to 14.2%. The aim of the present study was to as-sess the impact on patient’s quality of life and symptoms of Flower pollen extract in asso-ciation with vitamins (Deprox 500®) in compa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macchione, Nicola, Bernardini, Paolo, Piacentini, Igor, Mangiarotti, Barbara, Del Nero, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751341/ https://www.ncbi.nlm.nih.gov/pubmed/30488800 http://dx.doi.org/10.2174/1871523018666181128164252

Ejemplares similares

Is Serenoa repens Effective in the Treatment of Benign Prostatic Hyperplasia?
por: Çeker, Gökhan
Publicado: (2020)

Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?
por: Murugusundram, Sundaram
Publicado: (2009)

The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial
por: Zhang, Kai, et al.
Publicado: (2021)

A substitute variety for agronomically and medicinally important Serenoa repens (saw palmetto)
por: Jaiswal, Yogini, et al.
Publicado: (2019)

Comparison of the Phytochemical Composition of Serenoa repens Extracts by a Multiplexed Metabolomic Approach
por: Marti, Guillaume, et al.
Publicado: (2019)

Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia
por: Blair, Hannah A.
Publicado: (2022)

Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene
por: Minutoli, Letteria, et al.
Publicado: (2014)

Correction to: Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia
por: Blair, Hannah A.
Publicado: (2022)

The Role of Combination Therapy with α-Blockers and Hexanic Extract of Serenoa repens in the Treatment of LUTS/BPH
por: De Nunzio, Cosimo, et al.
Publicado: (2022)

Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
por: Cai, Tong, et al.
Publicado: (2020)

Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
por: Alcaraz, Antonio, et al.
Publicado: (2021)

Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms
por: De Monte, Celeste, et al.
Publicado: (2014)

Lipomatrix: A Novel Ascorbyl Palmitate-Based Lipid Matrix to Enhancing Enteric Absorption of Serenoa Repens Oil
por: Fratter, Andrea, et al.
Publicado: (2019)

Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH)
por: Saponaro, Miriam, et al.
Publicado: (2020)

Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
por: Sirab, Nanor, et al.
Publicado: (2013)

Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma
por: Silvestri, Ida, et al.
Publicado: (2013)

Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone
por: Boeri, Luca, et al.
Publicado: (2017)

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
por: Trivisonno, Leonel Fabrizio, et al.
Publicado: (2021)

Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study
por: Morgia, Giuseppe, et al.
Publicado: (2017)

The Clinical Impact of Hexanic Extract of Serenoa repens in Men with Prostatic Inflammation: A Post Hoc Analysis of a Randomized Biopsy Study
por: Samarinas, Michael, et al.
Publicado: (2020)

Observational study: daily treatment with a new compound “tradamixina” plus serenoa repens for two months improved the lower urinary tract symptoms
por: Iacono, Fabrizio, et al.
Publicado: (2012)

Effects of hexanic extract of serenoa repens (permixon(®) 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia
por: Latil, Alain, et al.
Publicado: (2015)

Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study
por: Alcaraz, Antonio, et al.
Publicado: (2020)

Retraction Note: Observational study: daily treatment with a new compound “tradamixina” plus serenoa repens for two months improved the lower urinary tract symptoms
por: Iacono, Fabrizio, et al.
Publicado: (2016)

Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure
por: Governa, Paolo, et al.
Publicado: (2016)

Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study
por: Alcaraz, Antonio, et al.
Publicado: (2022)

Pollen extract in association with vitamins provides early pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome
por: CAI, TOMMASO, et al.
Publicado: (2014)

The role of flower pollen extract in managing patients affected by chronic prostatitis/chronic pelvic pain syndrome: a comprehensive analysis of all published clinical trials
por: Cai, Tommaso, et al.
Publicado: (2017)

Trifolium pratense and T. repens (Leguminosae): Edible Flower Extracts as Functional Ingredients
por: Tundis, Rosa, et al.
Publicado: (2015)

The Clinical Efficacy of Pollen Extract and Vitamins on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Is Linked to a Decrease in the Pro-Inflammatory Cytokine Interleukin-8
por: Cai, Tommaso, et al.
Publicado: (2017)

Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
por: Alcaraz, Antonio, et al.
Publicado: (2022)

The economy of pollen dispersal in flowering plants
por: Johnson, Steven D., et al.
Publicado: (2023)

In Which Way Do the Flower Properties of the Specialist Orchid Goodyera repens Meet the Requirements of Its Generalist Pollinators?
por: Brzosko, Emilia, et al.
Publicado: (2023)

Autochthonous Dirofilaria repens in Austria
por: Silbermayr, Katja, et al.
Publicado: (2014)

A Case of Dermatitis Repens
por: Nicol, J. Wyllie
Publicado: (1909)

Dirofilaria repens infection of the eye
por: Engelsberg, Karl, et al.
Publicado: (2022)

Vaccinium Crassifolium Aut Repens
Publicado: (1880)

Trifolium Repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway
por: Sarno, Federica, et al.
Publicado: (2020)

Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study
por: Iwamura, Hiromichi, et al.
Publicado: (2015)

Flower movement balances pollinator needs and pollen protection
por: Haverkamp, Alexander, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i1f43iqd25t2ojit6r9ls5ap1r